Skip to content
Disclosery

EXANE DERIVATIVES: BIP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BIP, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,024 BIP shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,024 shares
    Change vs previous 13F -10,221 shares

    0.07% of the 13F portfolio, value $115,554.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 13,245 shares
    Change vs previous 13F +1,237 shares

    0.25% of the 13F portfolio, value $877,162.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 12,008 shares
    Change vs previous 13F +7,680 shares

    0.18% of the 13F portfolio, value $730,175.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,328 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $242,835.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).